Barclays PLC Rigel Pharmaceuticals Inc Transaction History

Barclays PLC

$327 Billion
Q2 2024

A detailed history of Barclays PLC transactions in Rigel Pharmaceuticals Inc stock. As of the latest transaction made, Barclays PLC holds 10,573 shares of RIGL stock, worth $144,850. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,573

Previous 150,568 92.98%

Holding current value

$144,850

Previous $223,000 60.54%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.79 - $9.53 $110,596 - $1.33 Million	-139,995 Reduced 92.98%	10,573 $88,000
Q1 2024 May 15, 2024	SELL	$1.12 - $1.57 $107,447 - $150,617	-95,935 Reduced 38.92%	150,568 $223,000
Q4 2023 Feb 15, 2024	BUY	$0.72 - $1.56 $147,495 - $319,573	204,855 Added 491.87%	246,503 $357,000
Q3 2023 Nov 07, 2023	SELL	$1.07 - $1.39 $4,117 - $5,348	-3,848 Reduced 8.46%	41,648 $45,000
Q2 2023 Aug 03, 2023	SELL	$1.12 - $1.82 $59,597 - $96,845	-53,212 Reduced 53.91%	45,496 $59,000
Q1 2023 May 04, 2023	BUY	$1.25 - $2.0 $65,465 - $104,744	52,372 Added 113.03%	98,708 $131,000
Q4 2022 Feb 13, 2023	BUY	$0.67 - $11.9 $26,142 - $464,326	39,019 Added 533.26%	46,336 $69,000
Q3 2022 Nov 03, 2022	SELL	$1.1 - $12.2 $1,478 - $16,396	-1,344 Reduced 15.52%	7,317 $9,000
Q2 2022 Aug 12, 2022	SELL	$0.67 - $3.19 $26,710 - $127,175	-39,867 Reduced 82.15%	8,661 $10,000
Q1 2022 May 16, 2022	SELL	$2.22 - $3.45 $352,662 - $548,056	-158,857 Reduced 76.6%	48,528 $145,000
Q4 2021 Feb 14, 2022	SELL	$2.36 - $3.57 $353,667 - $534,996	-149,859 Reduced 41.95%	207,385 $550,000
Q3 2021 Nov 09, 2021	BUY	$3.5 - $4.5 $422,772 - $543,564	120,792 Added 51.09%	357,244 $1.3 Million
Q2 2021 Aug 13, 2021	SELL	$3.09 - $4.54 $579,285 - $851,118	-187,471 Reduced 44.22%	236,452 $1.03 Million
Q1 2021 May 13, 2021	BUY	$3.35 - $4.93 $904,620 - $1.33 Million	270,036 Added 175.48%	423,923 $1.45 Million
Q4 2020 Feb 11, 2021	SELL	$2.35 - $3.74 $71,468 - $113,740	-30,412 Reduced 16.5%	153,887 $538,000
Q3 2020 Nov 12, 2020	SELL	$1.78 - $4.13 $115,094 - $267,045	-64,660 Reduced 25.97%	184,299 $441,000
Q2 2020 Aug 12, 2020	BUY	$1.41 - $2.05 $57,110 - $83,033	40,504 Added 19.43%	248,959 $456,000
Q1 2020 May 13, 2020	SELL	$1.27 - $3.0 $47,315 - $111,768	-37,256 Reduced 15.16%	208,455 $325,000
Q4 2019 Feb 10, 2020	BUY	$1.6 - $2.43 $57,945 - $88,004	36,216 Added 17.29%	245,711 $526,000
Q3 2019 Nov 14, 2019	BUY	$1.63 - $2.62 $65,817 - $105,792	40,379 Added 23.88%	209,495 $392,000
Q2 2019 Aug 14, 2019	BUY	$2.02 - $2.61 $123,230 - $159,223	61,005 Added 56.43%	169,116 $442,000
Q1 2019 May 15, 2019	BUY	$2.0 - $2.65 $16,024 - $21,231	8,012 Added 8.0%	108,111 $278,000
Q4 2018 Feb 14, 2019	SELL	$2.08 - $3.36 $352,468 - $569,372	-169,456 Reduced 62.87%	100,099 $230,000
Q3 2018 Nov 14, 2018	SELL	$2.6 - $3.59 $820,430 - $1.13 Million	-315,550 Reduced 53.93%	269,555 $866,000
Q2 2018 Aug 14, 2018	SELL	$2.83 - $4.11 $966,628 - $1.4 Million	-341,565 Reduced 36.86%	585,105 $1.66 Million
Q1 2018 May 15, 2018	BUY	$3.54 - $4.54 $1.77 Million - $2.27 Million	500,679 Added 117.53%	926,670 $3.28 Million
Q4 2017 Feb 14, 2018	BUY	$3.23 - $4.3 $832,351 - $1.11 Million	257,694 Added 153.12%	425,991 $1.65 Million
Q3 2017 Nov 14, 2017	BUY	$2.18 - $2.57 $366,887 - $432,523	168,297	168,297 $427,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

355K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.37B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account